A detailed history of Menard Financial Group LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Menard Financial Group LLC holds 12,283 shares of NVO stock, worth $1.23 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares
12,283
Previous 12,181 0.84%
Holding current value
$1.23 Million
Previous $1.74 Million 15.88%
% of portfolio
1.0%
Previous 1.29%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.07 - $145.42 $12,145 - $14,832
102 Added 0.84%
12,283 $1.46 Million
Q2 2024

Aug 09, 2024

BUY
$122.71 - $146.91 $17,302 - $20,714
141 Added 1.17%
12,181 $1.74 Million
Q1 2024

May 13, 2024

SELL
$102.11 - $135.92 $175,935 - $234,190
-1,723 Reduced 12.52%
12,040 $1.55 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $1.06 Million - $2.32 Million
11,645 Added 549.81%
13,763 $1.25 Million
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $330,365 - $365,672
2,118 New
2,118 $342,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $225B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Menard Financial Group LLC Portfolio

Follow Menard Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Menard Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Menard Financial Group LLC with notifications on news.